tiprankstipranks
Impact BioMedical, Inc. (IBO)
NYSE MKT:IBO
US Market
Holding IBO?
Track your performance easily

Impact BioMedical, Inc. (IBO) Income Statement

15 Followers

Impact BioMedical, Inc. Income Statement

Last quarter (Q ), Impact BioMedical, Inc.'s total revenue was $―, a decrease of ― from the same quarter last year. In Q, Impact BioMedical, Inc.'s net income was $4.25M. See Impact BioMedical, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22
Total Revenue
$ -148.00K-$ 50.00K
Cost of Revenue
---
Gross Profit
$ -148.00K-$ 50.00K
Operating Expense
$ 3.50M$ 4.03M$ 3.45M
Operating Income
$ -3.65M$ -4.03M$ -3.40M
Net Non Operating Interest Income Expense
$ -908.00K$ -431.00K$ -438.00K
Other Income Expense
$ -5.65M$ -52.00K$ -66.00K
Pretax Income
$ 1.10M$ -4.41M$ -7.88M
Tax Provision
-$ -1.01M$ -621.00K
Earnings From Equity Interest Net Of Tax
---
Net Income Common Stockholders
$ 981.00K$ -4.41M$ -7.05M
Basic EPS
$ 0.18$ -0.07$ -0.10
Diluted EPS
$ -0.13$ -0.07$ -0.10
Basic Average Shares
$ -7.55B$ 60.25M$ 70.50M
Diluted Average Shares
$ -7.55B$ 60.25M$ 70.50M
Dividend Per Share
---
Total Operating Income As Reported
---
Reported Normalized Basic E P S
---
Reported Normalized Diluted E P S
---
Rent Expense Supplemental
---
Total Expenses
$ 3.50M$ 4.03M$ 3.45M
Net Income From Continuing And Discontinued Operation
$ 981.00K$ -4.41M$ -7.05M
Normalized Income
$ 1.41M$ -5.42M$ -4.40M
Interest Expense
---
EBIT
$ 2.02M$ -5.05M$ -7.41M
EBITDA
$ 3.14M$ -3.93M$ -6.30M
Currency in USD

Impact BioMedical, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis